Gary K. Lee
Chief Scientific Officer, Lyell Immunopharma, Inc.
Companies
- Lyell Immunopharma, Inc.Chief Scientific Officer Feb 4, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lyell Immunopharma, Inc. LYEL16,220 shares2$132.8K at $8.19Aug 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 21, 2026Sold 1,457 shares at $15.54 of Lyell Immunopharma, Inc.2
- Aug 10, 2026Sold 131 shares at $14.34 of Lyell Immunopharma, Inc.3
- May 11, 2026Sold 130 shares at $18.92 of Lyell Immunopharma, Inc.4
- Feb 11, 2026Sold 1,671 shares at $23.39 of Lyell Immunopharma, Inc.5
- Feb 10, 2026Sold 147 shares at $23.12 of Lyell Immunopharma, Inc.6
- Feb 9, 2026Granted 4,000 shares of Lyell Immunopharma, Inc.6
- Nov 10, 2025Sold 138 shares at $16.16 of Lyell Immunopharma, Inc.7
- Aug 21, 2025Sold 1,453 shares at $10.54 of Lyell Immunopharma, Inc.8
- Aug 20, 2025Granted 8,000 shares of Lyell Immunopharma, Inc.8
- Aug 12, 2025Sold 136 shares at $10.34 of Lyell Immunopharma, Inc.9
- Aug 11, 2025Sold 131 shares at $10.53 of Lyell Immunopharma, Inc.9
- Feb 10, 2025Granted 112,500 shares of Lyell Immunopharma, Inc.10
- Feb 9, 2024Granted 40,000 shares of Lyell Immunopharma, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Aug 11, 2026
- 4SEC EDGARForm 4 filed Jun 15, 2026
- 5SEC EDGARForm 4 filed Feb 12, 2026
- 6SEC EDGARForm 4 filed Feb 11, 2026
- 7SEC EDGARForm 4 filed Nov 12, 2025
- 8SEC EDGARForm 4 filed Aug 22, 2025
- 9SEC EDGARForm 4 filed Aug 13, 2025
- 10SEC EDGARForm 4 filed Feb 26, 2025
- 11SEC EDGARForm 4 filed Feb 13, 2024